Dallah Healthcare Company

Equities

4004

SA135G51UI10

Healthcare Facilities & Services

End-of-day quote Saudi Arabian S.E. 06:00:00 2024-05-01 pm EDT 5-day change 1st Jan Change
162 SAR 0.00% Intraday chart for Dallah Healthcare Company -0.74% -5.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Dallah Healthcare Logs Higher FY23 Net Profit, Revenue MT
Ayyan Investment Appoints Financial Adviser for Share Exchange Deal with Dallah Healthcare MT
Dallah Healthcare Company signed of a non-binding memorandum agreement to acquire 97% stake in Al-Ahsa Medical Services Company and 100% stake in Al-Salam Medical Services Company from Ayyan Investment Company. CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for the Fourth Quarter of 2023, Payable on 30 January 2024 CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Dallah Healthcare Company completed the acquisition of an additional 18.98% stake in International Medical Centre. CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for Second Half of the Fiscal Year 2022, Payable on December 29, 2022 CI
Dallah Healthcare Company Approves Resignation of Fahad Bin Abdulaziz Al-Rabiah as Board of Directors and Compensation and Remuneration Committee CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Dallah Healthcare Company Approves Board Appointments CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2022 CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dallah Healthcare Company Receives Ministry of Health's Approval to Increase the Operational Capacity of Dallah Namar Hospital by 150 Additional Beds CI
Dallah Healthcare Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Dallah Healthcare Company signed of a non-binding memorandum of understanding to acquire an additional 18.98% stake in International Medical Centre. CI
Dallah Healthcare Company Reports Earnings Results for the Third Quarter Ended September 30, 2021 CI
Dallah Healthcare Company signed an agreement to acquire a 8.2% stake in International Medical Centre from Abdulaziz Mohammed Al Meshaal and Abeer Mohammed Al Meashaal for approximately SAR 290 million. CI
Dallah Healthcare to Seek Acquisition CI
Dallah Healthcare Co. Announces the Distribution of Cash Dividends for First Half of 2021 CI
Dallah Healthcare Company Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Chart Dallah Healthcare Company
More charts
Dallah Healthcare Company SJSC, formerly Dallah Healthcare Co, is a Saudi Arabia-based company engaged in the provision and operation of healthcare programs and utilities. The Company operates in the following business segments: Hospitals; Medicines, and Head Office. The Hospitals’ segment objectives are to own, manage, operate and maintain healthcare facilities. The Medicines’ segment objectives are to import, distribute, wholesale and retail medicines, as well as manufacture medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging materials. The Head Office’s segment objectives are to operate, manage and maintain healthcare facilities; wholesale and retail surgical equipment, artificial parts, handicapped and hospitals equipment, as well as other supporting services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
10
Last Close Price
162 SAR
Average target price
154.4 SAR
Spread / Average Target
-4.70%
Consensus
  1. Stock Market
  2. Equities
  3. 4004 Stock
  4. News Dallah Healthcare Company
  5. Dallah Healthcare Logs Higher FY23 Net Profit, Revenue